Ryotaro Nakamura

Medicine · Health Sciences

63h-index13.8kcitations581works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(267), Acute Lymphoblastic Leukemia research(145), Acute Myeloid Leukemia Research(140), Chronic Myeloid Leukemia Treatments(88), Immune Cell Function and Interaction(59)

Publications581 total

Interim Report of a Randomized Open Label Pilot Study of Human Lysozyme Goat Milk (hLZ) in Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
Transplantation and Cellular Therapy·2026
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study
Blood Advances·2025· 1 citedOpen Access
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis
Bone Marrow Transplantation·2025Open Access
Real world outcomes of patients with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation after induction with liposomal daunorubicin-cytarabine (CPX-351)
Leukemia & lymphoma/Leukemia and lymphoma·2025
Clinical activity, tolerability, and pharmacodynamics of ulviprubart in patients with T-cell large granular lymphocytic leukemia: Interim Results of A phase 1 trial
Blood·2025Open Access
The effect of belumosudil on the therapeutic monitoring of tacrolimus and sirolimus in allogeneic hematopoietic transplantation
Blood·2025
Ornithine decarboxylase deficiency in donor T cells preserves strong GVL activity while attenuating acute and preventing steroid-resistant gut GVHD in a recipient tissue PD-L1-dependent manner
Blood·2025Open Access
The addition of venetoclax to FLAG IDA or FCE in relapsed or refractory (R/R) acute myeloid leukemia (AML)
Blood·2025Open Access
Competing risk model of relapse versus non-relapse mortality in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Blood·2025Open Access
Post-transplant cyclophosphamide-based graft-verses-host disease (GVHD) prophylaxis is associated with a low incidence of fibrotic chronic GVHD after allogeneic hematopoietic cell transplantation across diverse donor types
Blood·2025Open Access
Exploratory risk score incorporating donor type, MF-HCT high-risk mutations, and day 100 chimerism for outcome stratification in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Blood·2025Open Access
A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia
Blood·2025Open Access
First-in-human phase I trial combining radiopharmaceutical therapy (RPT) using a 90y-anti-CD25 monoclonal antibody (Mab) with total marrow and lymphoid irradiation (TMLI) in relapsed or refractory (R/R) acute leukemia
Blood·2025
Intensive chemotherapy bridging to allogeneic hematopoietic cell transplant in relapsed or refractory Acute Myeloid Leukemia
Blood·2025
Outcomes of allogeneic hematopoietic cell transplant (HCT) in patients with TP53-altered acute leukemia or myelodysplastic syndrome: A retrospective single center analysis
Blood·2025Open Access
Day 7 mount sinai acute GVHD international consortium (MAGIC) algorithm probability predicts GVHD and non-GVHD-related non-relapse mortality in a contemporary cohort of allogeneic transplant patients
Blood·2025Open Access
Clearance of RAS pathway mutations prior to allogeneic transplant in Acute Myeloid Leukemia are associated with favorable overall and leukemia free survival
Blood·2025Open Access
Trial in progress: Pilot trial of olutasidenib maintenance post allogeneic hematopoietic cell transplantation in patients carrying IDH1 mutation with AML, MDS, or CMML
Blood·2025Open Access
Poor nutritional intake prior to allogeneic hematopoietic cell transplantation is associated with higher incidence of lower-gastrointestinal graft-versus-host disease
Blood·2025Open Access
Evolutionary divergence of polymorphic HLA residues predicts clinical outcomes after haploidentical stem cell transplantation in patients with AML
Blood·2025Open Access
page 1 of 30Next →

Frequent Co-authors

Stephen J. Forman(16), Vinod Pullarkat(9), Corey Cutler(7), Monzr M. Al Malki(7), Haris Ali(7), David S. Snyder(7), Wael Saber(7), Steven M. Devine(6), Mary M. Horowitz(6), Samer K. Khaled(6), Margaret O’Donnell(6), Anthony S. Stein(6), William J. Hogan(6), Neal S. Young(5), Asad Bashey(5), Miguel‐Angel Perales(5), Madan Jagasia(5), Ibrahim Aldoss(5), Ahmed Aribi(5), Amandeep Salhotra(5)